1. Home
  2. APGE vs IHS Comparison

APGE vs IHS Comparison

Compare APGE & IHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APGE
  • IHS
  • Stock Information
  • Founded
  • APGE 2022
  • IHS 2001
  • Country
  • APGE United States
  • IHS United Kingdom
  • Employees
  • APGE N/A
  • IHS N/A
  • Industry
  • APGE Biotechnology: Biological Products (No Diagnostic Substances)
  • IHS Telecommunications Equipment
  • Sector
  • APGE Health Care
  • IHS Telecommunications
  • Exchange
  • APGE Nasdaq
  • IHS Nasdaq
  • Market Cap
  • APGE 2.0B
  • IHS 2.1B
  • IPO Year
  • APGE 2023
  • IHS 2021
  • Fundamental
  • Price
  • APGE $37.87
  • IHS $7.28
  • Analyst Decision
  • APGE Strong Buy
  • IHS Strong Buy
  • Analyst Count
  • APGE 5
  • IHS 7
  • Target Price
  • APGE $95.40
  • IHS $10.18
  • AVG Volume (30 Days)
  • APGE 431.7K
  • IHS 598.6K
  • Earning Date
  • APGE 08-11-2025
  • IHS 08-12-2025
  • Dividend Yield
  • APGE N/A
  • IHS N/A
  • EPS Growth
  • APGE N/A
  • IHS N/A
  • EPS
  • APGE N/A
  • IHS 0.33
  • Revenue
  • APGE N/A
  • IHS $1,731,025,000.00
  • Revenue This Year
  • APGE N/A
  • IHS $1.97
  • Revenue Next Year
  • APGE N/A
  • IHS $5.50
  • P/E Ratio
  • APGE N/A
  • IHS $22.28
  • Revenue Growth
  • APGE N/A
  • IHS N/A
  • 52 Week Low
  • APGE $26.20
  • IHS $2.44
  • 52 Week High
  • APGE $63.50
  • IHS $7.52
  • Technical
  • Relative Strength Index (RSI)
  • APGE 51.33
  • IHS 61.38
  • Support Level
  • APGE $35.68
  • IHS $6.92
  • Resistance Level
  • APGE $38.75
  • IHS $7.43
  • Average True Range (ATR)
  • APGE 1.59
  • IHS 0.23
  • MACD
  • APGE 0.19
  • IHS -0.02
  • Stochastic Oscillator
  • APGE 69.51
  • IHS 72.09

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

About IHS IHS Holding Limited

IHS Holding Ltd is an independent owner, operator, and developer of shared telecommunications infrastructure. The company provides telecommunications infrastructure to its customers, who are MNOs, who in turn provide wireless voice and data services to their end-users. Its geographical segments are Nigeria, Sub-Saharan Africa, the Middle East and North Africa (MENA), and Latin America (Latam). The majority of its revenue is derived from Nigeria.

Share on Social Networks: